Mylan Launches Generic Clolar For Injection

08:57 EST 9 Nov 2017 | Pharmaceutical Processing

This article has expired, however you can still download the PDF.
NewsMylan received final approval from the FDA for its Abbreviated New Drug Application. The product is indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia.Contributed Author: My...

Other Sources for this Article

Original Article: Mylan Launches Generic Clolar For Injection


More From BioPortfolio on "Mylan Launches Generic Clolar For Injection"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...